340B Answers Aligned with HRSA Policy
Assistance with your 340B questions is just a phone call, email, or chat away. When you have a 340B question, contact Apexus Answers, a free 340B information resource provided to promote program integrity for 340B Prime Vendor Program (PVP) participants and other stakeholders.
Apexus Answers aligns with HRSA policy and guidance. Our staff is in constant communication with HRSA to ensure that messaging is consistent. If our staff doesn't have the answer to your question, it will forward the issue to HRSA for clarification.
The Apexus Answers service is available Monday through Friday from 8:00 am to 5:00 pm (Central).
Your question may have already been asked and answered. Check out our Frequently Asked Questions (FAQs).
Reasons to contact Apexus Answers:
|HRSA 340B Database
||Guidance on all
|Program Eligibility Questions||Covered Outpatient Drugs||Medicaid/ Duplicate Discounts||Annual Recertification||Pricing|
|Change requests||The patient definition||Covered entities||Definition of Covered Outpatient Drug||State agency contact information||Assistance with login||Sub-WAC Pricing|
|Registration process||GPO Prohibition||Outpatient facilities||Exclusions; Orphan Drug and GPO Prohibition||Medicaid Exclusion File||Recertify/decertify||Pharmaceutical Pricing Agreement|
|Locating covered entity resources||Purchasing/Inventory||Contract pharmacies||340Bpvp.com Catalog||General policy||Status of submission/OPA review||Value added products|
Please be advised that responses from Apexus Answers are not dispositive with respect to compliance with or participatory status in the 340B Drug Pricing Program. 340B entities are ultimately responsible for 340B program compliance, and Apexus encourages entities to include legal counsel as part of their program integrity efforts.
The responsibility to ensure compliance with 340B program requirements remains with covered entities and manufacturers that participate. Information received from vendors, consultants, and other third parties cannot be assumed to be compliant with HRSA policy.